Van Eck Associates Raised By $345,033 Its Transglobe Energy (TGA) Holding; Macrogenics (MGNX)’s Sentiment Is 1.73

September 17, 2017 - By Vivian Currie

MacroGenics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing monoclonal antibody therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The company has market cap of $642.13 million. The Firm develops therapeutic product candidates using its antibody technology platforms and also in collaboration with other biopharmaceutical companies. It currently has negative earnings. It has a pipeline of product candidates in human clinical testing, primarily as treatments for different types of cancers, which are created using its technology platforms.

Van Eck Associates Corp increased Transglobe Energy Corp (TGA) stake by 147.16% reported in 2016Q4 SEC filing. Van Eck Associates Corp acquired 345,033 shares as Transglobe Energy Corp (TGA)’s stock declined 8.33%. The Van Eck Associates Corp holds 579,487 shares with $979,000 value, up from 234,454 last quarter. Transglobe Energy Corp now has $77.18M valuation. The stock decreased 13.71% or $0.17 on September 15, reaching $1.07. About 438,838 shares traded or 495.40% up from the average. TransGlobe Energy Corporation (USA) (NASDAQ:TGA) has declined 11.88% since September 17, 2016 and is downtrending. It has underperformed by 28.58% the S&P500.

Among 2 analysts covering Transglobe Energy (NASDAQ:TGA), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Transglobe Energy had 2 analyst reports since January 14, 2016 according to SRatingsIntel. The stock of TransGlobe Energy Corporation (USA) (NASDAQ:TGA) has “Sector Underperform” rating given on Thursday, January 14 by IBC. The stock of TransGlobe Energy Corporation (USA) (NASDAQ:TGA) earned “Mkt Perform” rating by Raymond James on Monday, February 13.

Van Eck Associates Corp decreased Mainstay Definedterm Municipal Opportun (MMD) stake by 23,768 shares to 54,699 valued at $1.00 million in 2016Q4. It also reduced Dominion Resources Inc/Va (NYSE:DCUC) stake by 16,370 shares and now owns 141,464 shares. Incyte Corp (NASDAQ:INCY) was reduced too.

Dafna Capital Management Llc holds 1.6% of its portfolio in MacroGenics Inc for 89,200 shares. Bb Biotech Ag owns 1.92 million shares or 1.45% of their US portfolio. Moreover, Tanaka Capital Management Inc has 1.21% invested in the company for 25,250 shares. The Massachusetts-based Eventide Asset Management Llc has invested 0.97% in the stock. Tiger Management L.L.C., a New York-based fund reported 239,667 shares.

Analysts await MacroGenics Inc (NASDAQ:MGNX) to report earnings on November, 1. They expect $-1.03 earnings per share, down 6.19% or $0.06 from last year’s $-0.97 per share. After $-1.14 actual earnings per share reported by MacroGenics Inc for the previous quarter, Wall Street now forecasts -9.65% EPS growth.

Since January 1, 0001, it had 0 buys, and 1 insider sale for $100,000 activity.

The stock increased 2.05% or $0.35 on September 15, reaching $17.45. About 317,331 shares traded or 47.70% up from the average. MacroGenics Inc (MGNX) has declined 9.76% since September 17, 2016 and is downtrending. It has underperformed by 26.46% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :